Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PFSAthis companyProfusa, Inc. Common Stock	$0.55	-7.35×	-9.87×	0×	-8.99×	-8597.3%	0.0%	0.0%	0.0%	134.4%	114.5%	-6.2%	-0.56×	-0.42×	-2.6×	0.17×	0.0%	2	-374.82	2	C
ACXPAcurx Pharmaceuticals, Inc.	$1.07	-0.47×	0.71×	0×	0.48×	374.0%	0.0%	0.0%	0.0%	-151.2%	-153.6%	-181.9%	0×	0.95×	0×	3.18×	0.0%	2	-10.22	2	B-
APREAprea Therapeutics, Inc.	$0.54	-0.44×	0.45×	0×	0.72×	335.0%	0.0%	0.0%	0.0%	-101.3%	-100.5%	-231.2%	0×	1.16×	0×	5.63×	0.0%	3	-10.16	2	C+
BCDABioCardia, Inc.	$0.90	-1.02×	9.31×	0×	-0.82×	-76.9%	0.0%	0.0%	0.0%	-919.3%	-581.7%	-89.3%	0.59×	0.25×	0×	1.12×	0.0%	1	-51.25	2	C
BFRIBiofrontera Inc.	$0.83	-0.55×	0.55×	0.14×	-0.61×	-3679.1%	78.7%	-21.9%	-25.3%	-100.5%	-53.8%	-230.5%	0.59×	0.03×	-20.24×	1.52×	0.0%	2	-6.17	1	C-
HCWBHCW Biologics Inc.	$1.02	-0.09×	0.74×	37.52×	-1.22×	-4178.9%	20.0%	-20757.6%	-14677.1%	-287.9%	-109.7%	-658.1%	2.46×	-0.86×	-9×	0.11×	0.0%	2	-6.89	2	C
Peer median	—	-0.47×	0.71×	0×	-0.61×	-76.9%	0.0%	0.0%	0.0%	-151.2%	-109.7%	-230.5%	0.59×	0.25×	0×	1.52×	0.0%	2	-10.16	2	—